Major Publications

 

Major Publications using our products

 

 

MDA modified LDL and apoB-100 were applied in this study

A° sa Stro¨m, Gunilla Nordin Fredrikson, Alexandru Schiopu, Irena Ljungcrantz, Ingrid S¨oderberg, Bo Jansson, Roland Carlsson, Anna Hultg°ardh-Nilsson, Jan Nilsson; Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100; Atherosclerosis 190 (2007) 298–305.

 

---

 

MDA modified LDL and apoB-100 were applied in this study

Lindgren, Mikko P.S. Ares, Prediman K. Shah, Roland Carlsson, Jan Nilsson and Alexandru Schiopu, Jenny Bengtsson, Ingrid Söderberg, Sabina Janciauskiene, Stefan; B-100 Peptide Sequences Inhibit Atherosclerosis Recombinant Human Antibodies Against Aldehyde-Modified Apolipoprotein; Circulation 2004;110;2047-2052.

 

---

 

ApoC-I and ApoC-III were applied in this study

Antonina Kolmakova, Peter Kwiterovich, Donna Virgil, Petar Alaupovic, Carolyn Knight-Gibson, Sergio F. Martin, Subroto Chatterjee. Apolipoprotein C-I Induces Apoptosis in Human Aortic Smooth Muscle Cells via Recruiting Neutral Sphingomyelinase. Arterioscler Thromb Vasc Biol. 2004; 24:264-269

 

---

 

HRP-conjugated goat anti-human apo A-II, apo E, apo A-I, and apo B were applied in this study

Baiba K. Gillard, Harry S. Courtney, John B. Massey, and Henry J. Pownall. Serum Opacity Factor Unmasks Human Plasma High-Density Lipoprotein Instability via Selective Delipidation and Apolipoprotein A-I Desorption. Biochemistry 2007, 46, 12968-12978.

 

---

 

Goat anti-human polyclonal antibodies to apoA-I, apoA-II, apoC-I, apoC-II, apoC-III, and apoE were applied for mass spectrometric assays

Dobrin Nedelkov, Urban A. Kiernan, Eric E. Niederkofler, Kemmons A. Tubbs, and Randall W. Nelson. Investigating diversity in human plasma proteins. PNAS, 2005, August 2, 102:10852-10857.

 

---